Exploring a Tetrahydroquinoline Antimalarial Hit from the Medicines for Malaria Pathogen Box and Identification of its Mode of Resistance as
<i>Pf</i>
eEF2
作者:Benoît Laleu、Kelly Rubiano、Tomas Yeo、Irene Hallyburton、Mark Anderson、Benigno Crespo‐Fernandez、Francisco‐Javier Gamo、Yevgeniya Antonova‐Koch、Pamela Orjuela‐Sanchez、Sergio Wittlin、Gouranga P. Jana、Bikash C. Maity、Elodie Chenu、James Duffy、Peter Sjö、David Waterson、Elizabeth Winzeler、Eric Guantai、David A. Fidock、Thomas G. Hansson
DOI:10.1002/cmdc.202200393
日期:2022.11.18
report an exploration of the antimalarial compound MMV692140. The mode of resistance was identified as PfeEF2. The structural motif was explored in a chemistry program, resulting in the identification of MMV1919557, an analog with significantly improved antimalarial potency. This new series could provide a tool to further understand the potential of PfeEF2 as a target for malaria treatment.
工具包扩展:我们报告了抗疟化合物 MMV692140 的探索。耐药模式被确定为Pf eEF2。在化学程序中探索了结构基序,从而鉴定出 MMV1919557,这是一种抗疟药效显着提高的类似物。这个新系列可以提供一种工具,以进一步了解Pf eEF2 作为疟疾治疗靶标的潜力。